
Scan how Keurig Dr Pepper's latest earnings and the Keurig Alta launch compare to peers by reviewing 19 high quality undiscovered gems with similar product momentum and solid fundamentals.
Keurig Dr Pepper asks you to believe that its beverage and coffee platforms can both carry their weight while the group reshapes into two focused businesses. The third quarter showed US$7.344b in sales and US$882m in net income, with full year 2026 net sales guidance reaffirmed at US$25.9b to US$26.4b, so the near term revenue story has not radically shifted.
The short term swing factor remains execution in U.S. Coffee and cost control, given earlier pressure from input costs and weaker pod volumes in that segment. The biggest risk is that coffee category strain, including competitive pricing and tariffs on green coffee or brewers, persists long enough to keep margins soft while leverage and separation work continue.
The launch of the Keurig Alta system is the clearest operational catalyst tied to these results. Alta introduces higher priced at home brewing hardware with compostable AltaRounds, and it remains compatible with existing K Cup pods. This extends the installed base rather than abandoning it and targets more premium, café style occasions.
For investors tracking the analyst consensus Narrative on Simply Wall St, Alta sits alongside the planned separation into Beverage Co and a global coffee focused company as a practical test of coffee execution. Uptake of a US$499.99 system and US$9.99 to US$10.99 pod packs, and how that mixes with existing pods, will matter for both volume resilience and how quickly Keurig Dr Pepper can offset cost and pricing pressure in its coffee operations.
Keurig Dr Pepper's current analyst storyline points to revenues of US$32.4b and earnings of US$3.2b by 2029, based on forecasts that assume about 11.9% yearly revenue growth and an earnings increase of roughly US$1.7b from US$1.5b today.
Uncover why Keurig Dr Pepper's fair value indicates a 3% potential downside to its current price, leaving little room for error.
The four fair value estimates from the Simply Wall St Community span a wide band, from US$35.50 at the low end to about US$103.50 at the top. Opinion on Keurig Dr Pepper is therefore far from settled. Set that against coffee segment cost pressure and the Alta rollout, and you are looking at genuinely different paths for future performance.
Explore 3 other Keurig Dr Pepper fair value estimates, including one that suggests as much as 7% downside from the current price.
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
If the Keurig Dr Pepper story has sharpened your thinking, use that momentum to broaden your watchlist with other stocks that match the kind of balance sheet strength, income potential, or value profile you want to focus on next.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com